Clinical Trial: Page 4

Reveal Genomics presents trial results for HER2Dx breast cancer test at SABCS
By LabPulse.com staff writers
The results show that an HER2Dx risk score was significantly associated with relapse-free interval and long-term survival outcomes; additionally, HER2Dx can identify patients who might be candidates for neoadjuvants or de-escalation of systemic therapy.
December 6, 2022
Breast Cancer2 Social
Diadem presents data at CTAD on blood test for early prediction of Alzheimer's
By LabPulse.com staff writers
The firm is preparing to launch a test next year that enables drug developers to identify with high confidence individuals who will experience a decline to Alzheimer's dementia up to six years in advance of diagnosis.
December 5, 2022
Brain Dementia Leaves Social
Global Health Innovative Technology obtains $20M grant over five years from Wellcome
By LabPulse.com staff writers
GHIT said that in 2023, the tenth anniversary of its founding, it will aim to streamline and accelerate research and development for malaria, tuberculosis, neglected tropical diseases, and other infectious diseases.
December 5, 2022
Research Money Social
Blood-based MDx test developer DiamiR to present poster on trial findings at CTAD
By LabPulse.com staff writers
The poster will be presented during the session “Clinical trials: Biomarkers including plasma” during the 15th Clinical Trials on Alzheimer’s Disease (CTAD) in San Francisco from November 29 to December 2.
November 28, 2022
Amyloid Plaque Alzheimer2 Social
AnchorDx enrolling U.S. clinical trial for bladder cancer assay
By LabPulse.com staff writers
The study, which will enroll more than 1,000 participants, aims to evaluate the noninvasive, qPCR assay which detects two DNA methylation biomarkers in urine specimens from patients suspected of having bladder cancer.
November 23, 2022
Bladder Urinary 3 D Social
Biological Dynamics embarks on clinical utility studies for pancreatic cancer detection assay
By LabPulse.com staff writers
Biological Dynamics said that it is collaborating with Qure Healthcare and Curta to also evaluate the effects of its pancreatic cancer detection assay on patient outcomes and healthcare economics.
November 23, 2022
Pancreatic Neuroendocrine Tumor Pnet Social
Roche points to results of heart failure study leveraging its cardiac hormone biomarker and test
By Jared Berberabe
The results were shared this week at an American Heart Association Late-Breaking Scientific Session and published simultaneously in the Lancet.
November 9, 2022
Cardiac Heart Eeg Social
SomaLogic touts NIH study of proteomic profiling platform
By LabPulse.com staff writers
According to company, researchers conducting the study found that the platform demonstrates strength in proteome coverage and sensitivity, and it provides consistently low variability.
October 28, 2022
Protein Molecule
Glympse to present data on the detection of hepatocellular carcinoma with biosensor platform
By LabPulse.com staff writers
In combination, the Glympse assay and a blood biomarker test demonstrated an area under the curve (AUC) of 0.90 in differentiating HCC and cirrhosis patients.
October 25, 2022
Liver Social
OpGen subsidiary Curetis collaborating with BioVersys on drug trial
By LabPulse.com staff writers
The clinical trial will use Unyvero HPN with hospitalized pneumonia patients to determine eligibility for enrollment in the study.
October 25, 2022
Bacteria Microscope Social
Self-supervised deep learning algorithm shows promise for rapid whole-slide-imaging retrieval
By Jared Berberabe
Brigham and Women’s Hospital researchers are developing an algorithm to speed whole-slide-imaging retrieval from large digital repositories.
October 19, 2022
Artificial Intelligence Ai Hand
Prelude Dx to present clinical utility data for DCIS risk assessment test
By LabPulse.com staff writers
DCISionRT predicts radiation therapy benefit through a risk assessment test for patients with ductal carcinoma in situ (DCIS).
October 21, 2022
Breast Cancer Social
Previous Page
Page 4 of 18
Next Page